G-CSF (filgrastim) as an adjunct to MOPP/ABVD therapy in Hodgkin's disease. [electronic resource]
Producer: 19971007Description: 483-8 p. digitalISSN:- 0284-186X
- Adult
- Antibiotics, Antineoplastic -- administration & dosage
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Agents, Alkylating -- administration & dosage
- Antineoplastic Agents, Hormonal -- administration & dosage
- Antineoplastic Agents, Phytogenic -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Bleomycin -- administration & dosage
- Case-Control Studies
- Dacarbazine -- administration & dosage
- Disease-Free Survival
- Doxorubicin -- administration & dosage
- Female
- Filgrastim
- Follow-Up Studies
- Granulocyte Colony-Stimulating Factor -- administration & dosage
- Hematinics -- administration & dosage
- Hodgkin Disease -- drug therapy
- Humans
- Male
- Mechlorethamine -- administration & dosage
- Middle Aged
- Neoplasm Recurrence, Local
- Neoplasm Staging
- Nervous System -- drug effects
- Neutropenia -- chemically induced
- Prednisone -- administration & dosage
- Procarbazine -- administration & dosage
- Recombinant Proteins
- Remission Induction
- Retrospective Studies
- Survival Rate
- Thrombocytopenia -- chemically induced
- Treatment Outcome
- Vinblastine -- administration & dosage
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.